Drug Trial Radar · NCT07543120
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
323
Planned (sponsor's estimate)
Start
May 7, 2026
Primary completion
May 7, 2031
Study completion Nov 7, 2031
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Apr 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.
Conditions
- Hypertension (HTN)
Interventions
QCZ484Drug
QCZ484 subcutaneous injection, Q6M.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with AEsTime frame: Up to 66 months
Locations
46 sites in 3 countries. Site status is shown where the registry gives one.
SEC Clinical Research LLC
Andalusia, Alabama · Recruiting
Synexus Clinical Research US Inc
Tucson, Arizona · Recruiting
NICRs Research Center
Garden Grove, California · Recruiting
Downtown L A Research Center Inc
Los Angeles, California · Recruiting
Clinical Research of Brandon LLC
Brandon, Florida · Recruiting
ALL Medical Research LLC
Cooper City, Florida · Recruiting
National Research Institute
Hialeah, Florida · Recruiting
East Coast Institute for Research
Jacksonville, Florida · Recruiting
Entrust Clinical Research
Miami, Florida · Recruiting
Inpatient Research Clinical LLC
Miami Lakes, Florida · Recruiting
American Research Centers of FL
Pembroke Pines, Florida · Recruiting
Cen Exel FCR
Tampa, Florida · Recruiting
Cardiology Partners Clinical Research Institute
Wellington, Florida · Recruiting
Javara Research
Fayetteville, Georgia · Recruiting
Javara Research
Fayetteville, Georgia · Recruiting
Cedar Crosse Research Ct
Chicago, Illinois · Recruiting
Eagle Clinical Research
Chicago, Illinois · Recruiting
Synexus Clinical Research US
Evansville, Indiana · Recruiting
Alliance for Multispecialty Research
Wichita, Kansas · Recruiting
Ascension Saint Agnes Heart Care
Baltimore, Maryland · Recruiting
Anderson Medical Research
Ft. Washington, Maryland · Recruiting
Capitol Cardiology Associates
Lanham, Maryland · Recruiting
Oakland Medical Research Center
Troy, Michigan · Recruiting
Synexus Clinical Research US Inc
Richfield, Minnesota · Recruiting
Jefferson City Medical Group
Jefferson City, Missouri · Recruiting
Clin Rsrch Consult a JCCT Company
Kansas City, Missouri · Recruiting
CenExel HRI
Berlin, New Jersey · Recruiting
Monroe Biomedical Research
Monroe, North Carolina · Recruiting
CR Services Acquisition US
Columbus, Ohio · Recruiting
Conrad Clinical Research
Edmond, Oklahoma · Recruiting
TCV Clinical Studies
Linwood, Pennsylvania · Recruiting
Velocity Clinical Research
Union, South Carolina · Recruiting
Clinical Neuroscience Solutions Inc
Memphis, Tennessee · Recruiting
Velocity Clinical Research Austin
Austin, Texas · Recruiting
Synergy Groups Medical LLC
Missouri City, Texas · Recruiting
Sun Research Institute
San Antonio, Texas · Recruiting
Manassas Clinical Research Center
Manassas, Virginia · Recruiting
Dominion Medical Associates
Richmond, Virginia · Recruiting
Novartis Investigative Site
Suita, Osaka, Japan · Recruiting
Novartis Investigative Site
Chuo Ku, Tokyo, Japan · Recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.